Description

Product Description

COVID-19 Saliva Antigen Rapid Test, is used for the qualitative detection of the COVID-19 antigen and detects the novel coronavirus N protein antigen, which can be detected in the early stage of viral infection and can be used as direct evidence of viral infection. It can be used as an auxiliary diagnostic index in clinical practice. The rapid test employs immunochromatography technology to detect the SARS-CoV-2 antigen in human saliva or nasal specimens.

Clinical sensitivity 98%,
Clinical specificity 100 %.
E Approved.!                                                                 

CAS-ENVISION-SARS-CoV-2 Antigen Rapid Detection kit

Specification:

High Accuracy, Specificity and Sensitivity

Test results within 15 minutes

12 Months Shelf Life

Room Temperature Storage

Nasal Swabs or Throat Swabs available

Easy to operate and requires no additional equipment

Clinical Performance;
The nasal swabs:
Relative Sensitivity: 97.5%
Relative Specificity: 99.2%
Accuracy: 98.4%
The oral and saliva swabs:
Relative Sensitivity: 95.8%
Relative Specificity:: 98.4%
Accuracy: 97.1%
CAS-Envision SARS-CoV-2 Antigen Rapid Detection Kit is a colloidal gold immunochromatography intended for the qualitative detection of nucleocapsid antigens from SARS-CoV-2 in human nasal or throat swab specimen.
The test provides preliminary test results but cannot be used as the sole basis for treatment or other management decision. Positive results indicate the presence of viral antigens, but do not rule out bacterial infection or co-infection with other viruses. Negative results do not rule out SARS-CoV-2 infection. The results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary for patient management.